Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/811240/000156459020013794/biol-10k_20191231.htm
|
Exhibit 99.1 |
BIOLASE REPORTS 2019 FOURTH QUARTER; NET REVENUE INCREASED 18% SEQUENTIALLY
–Full Year Gross Margin Increased by 120 Basis Points Year Over Year
–Fourth Quarter Operating Loss Improves by $3.5 Million Year Over Year
–Conference Call Today at 4:30pm ET
IRVINE, Calif., March 26, 2020
– BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported net revenue of $10.2 million and $37.8 million for the fourth quarter and year ended December 31, 2019, respectively.Sequential Fourth Quarter Results Demonstrate Sequential Operating Momentum
|
• |
Net revenue increased 18% sequentially |
|
• |
U.S. laser revenue increased 44% sequentially |
|
• |
International laser revenue increased 2% sequentially |
|
• |
Worldwide consumables and other revenue increased 1% sequentially |
|
• |
GAAP net loss decreased 48% year over year to $3.6 million |
|
• |
Adjusted EBITDA loss decreased 39% year over year to $1.6 million |
|
• |
Epic Hygiene laser for dental hygienists received FDA clearance in U.S. |
“We made significant progress in 2019 as we continued to transition BIOLASE from an R&D-centric company into a commercially-focused business,” commented Todd Norbe, President and Chief Executive Officer. “I believe the sequential improvement in the fourth quarter demonstrates the early success of our go-to-market strategy, under which we continue to rationalize our cost structure and rebuild our salesforce into a more disciplined customer-centric organization that is beginning to create positive change. I believe we have the right leadership team in place to achieve our growth and profitability objectives going forward.
“In December 2019, we received FDA clearance for our Epic Hygiene laser for dental hygienists, representing the achievement of another significant regulatory milestone, and just this week we received FDA clearance for LBR (laser bacterial reduction). This new laser system provides dental professionals a total solution to effectively manage non-surgical periodontitis. Our goal is to expand the reach of this great technology through increased awareness and improved sales and marketing execution.
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Biolase, Inc.
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/811240/000156459020013794/biol-10k_20191231.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years